Rx data firms sue Maine, Vermont

Share this article:
Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.

IMS Health, Wolters Kluwer Health and Verispan want to prevent statutes in the two states from taking effect Jan. 1.

A similar New Hampshire law that would have limited drug company access to doctors' prescribing habits was struck down in U.S. District Court in April on constitutional grounds. That ruling is under appeal.

The suits, filed in late August, say the Maine and Vermont statutes differ only slightly from the New Hampshire law and that they deny access to information that is central to improving the quality of care and ensuring patient safety.

But Vermont and Maine officials said that after the New Hampshire ruling, they altered their laws and would fight the lawsuit. “We will vigorously defend the constitutionality of the law and oppose efforts to have its enforcement enjoined,” Maine's attorney general told the AP.

Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.